Recent studies involving models of DN podocytes have found that downregulation of the miR-17∼92 cluster ameliorates inflammation and podocyte injury by targeting ABCA1 (ATP-binding cassette transporter A1) (Fan et al., 2020). The gene discussed is ABCA1; the disease is liver dysplastic nodule.